Topics

High BMI May Cut Overall Survival in HER2+ Metastatic Breast Cancer

07:01 EST 12 Feb 2020 | Drugs.com

WEDNESDAY, Feb. 12, 2020 -- For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (BMI) of ≥30 kg/m² is...

Original Article: High BMI May Cut Overall Survival in HER2+ Metastatic Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "High BMI May Cut Overall Survival in HER2+ Metastatic Breast Cancer"

Quick Search

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...